In brief
Since the Trump administration cut funding for international health initiatives, tuberculosis treatment systems have collapsed in numerous countries, including Kenya, leaving many patients like Dalvin Modore critically ill and spreading the disease within their communities.
In Kenya, patients suffering from tuberculosis (TB) are facing severe treatment disruptions after significant cuts to U.S. foreign aid initiated by the Trump administration. Dalvin Modore, a 40-year-old farmer, exemplifies the dire situation; he has lost so much weight that his clothes no longer fit, and he grapples with debilitating symptoms, including a persistent cough and occasional vomiting of blood. With the aid freeze taking effect on January 20, the landscape of TB care has drastically changed, leading to an increased spread of the disease.The U.S. previously contributed nearly half of the international funding for TB treatment, supporting crucial resources such as lab equipment and healthcare personnel in countries like Kenya. However, as funding has dwindled, many TB programs have collapsed, undermining the ability of healthcare systems to find, diagnose, and treat patients effectively. In the aftermath of these funding cuts, individuals like Modore are left without the necessary tests and medications to combat TB, resulting in a growing public health crisis.Administration officials contend that other nations must take a larger role in funding for global health programs, citing a need to evaluate foreign aid contracts in light of U.S. interests. Yet, the immediate consequences of these policies are prompting serious concerns from health advocates about the resurgence of tuberculosis and the critical need for international collaboration to address the issue. As patients suffer, many fear that without urgent action, the toll of tuberculosis, which is already the deadliest infectious disease worldwide, could worsen dramatically.
